We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Next Generation Automated Liquid Handling and Sample Preparation System Available in 2013

By LabMedica International staff writers
Posted on 15 Nov 2012
An innovative automatic liquid handling system will shortly be available for biotech and other life science laboratories.

The Agilent Technologies Inc. More...
(Santa Clara, CA, USA) Encore Multispan Liquid Handling System is expected to be ready for shipping in the second quarter of 2013.

This state-of-the-art instrument boasts a dual, multispan pipetting system that provides two individual banks of multiple pipettes where each moves independently in multiple axes, delivering ultimate speed and double the throughput of other automated liquid handling platforms available today. Each pipette is compatible with a variety of sample formats, from test tubes to vials to microplates.

The platform incorporates an innovative and powerful software package that features a three-dimensional simulator that provides the operator with the ability to set up, visualize, and optimize liquid delivery protocols remotely and offline prior to running them on the system.

The Encore Multispan Liquid Handling System was designed for a wide range of applications, including high-throughput screening, ELISA, drug discovery, compound management, and sample-preparation workflows for genomics, proteomics, and more.

“Agilent’s distinct expertise in both workflow automation and liquid handling has allowed us to integrate innovative technologies into a single platform, and empower scientists to take their research to the next level in terms of flexibility, throughput, and ultimately lab productivity,” said Yvonne Linney, vice president and general manager of automation solutions at Agilent. “With the introduction of the Encore Multispan System, Agilent is offering scientists the ability to reach beyond routine liquid handling and experience the highest levels of efficiency and productivity in their laboratories.”

“In partnership with our customers, we worked to understand the many bottlenecks and limitations associated with sample-prep automation and created a unique solution,” said Ms. Linney. “It combines advanced liquid handling and robotics to enable true sample-to-analysis automation.”

Related Links:
Agilent Technologies Inc.



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
HPV Molecular Test
BD Onclarity HPV Assay
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Graphical abstract (Pola, I., Akinyemi, T., Tan, K. et al. Nature Communications(2026). https://doi.org/10.1038/s41467-026-74971-4)

Blood Biomarker Study Reveals Population-Specific Differences in Alzheimer’s Disease

Blood-based biomarkers are emerging as tools for detecting Alzheimer’s disease–related changes without relying on advanced brain imaging or cerebrospinal fluid (CSF) analysis. However, much of the foundational... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.